A solar-powered airplane finished crossing the United States on Saturday, landing in New York City after flying over the Statue of Liberty during its historic bid to circle the globe, the project team said. The spindly, single-seat experimental aircraft, dubbed Solar Impulse 2, arrived at New York's John F. Kennedy International Airport at about 4 a.m. local time after it took off about five hours beforehand at Lehigh Valley International Airport in Pennsylvania, the team reported on the airplane's website. Such a pleasure to land in New York! For the 14th time we celebrate sustainability," said the project's co-founder Andre Borschberg on Twitter after flying over the city and the Statue of Liberty during the 14th leg of the trip around the globe. The Swiss team flying the aircraft in a campaign to build support for clean energy technologies hopes eventually to complete its circumnavigation in Abu Dhabi, where the journey began in March 2015. The solar cr...
A straightforward pee test that could identify pancreatic disease much sooner than at present has been created by researchers. They discovered a protein "signature" just present in individuals with the sickness. Pancreatic malignancy is regularly exceptionally progressed when it is analyzed - and just 3% of patients are alive five years after finding. Disease philanthropies respected the study, distributed in Clinical Cancer Research, saying a test was "highly required". Just shy of 9,000 individuals are determined to have pancreatic disease in the UK consistently. It has the most minimal five-year survival rate of any regular disease and one that has scarcely enhanced in 40 years. More than 80% of individuals with the infection are analyzed when it has spread, so they are not qualified for surgery to uproot the tumor - at present the main potential cure.
The research looked at almost 500 urine samples. Just under 200 were from patients with pancreatic cancer, 92 from patients with chronic pancreatitis and 87 from healthy volunteers.The rest of the samples were from patients with benign and cancerous liver and gall bladder conditions.
Out of 1,500 proteins found in the urine samples, three - LYVE1, REG1A and TFF1 - were seen to be at much higher levels in the pancreatic cancer patients, providing a "protein signature" that could identify the most common form of the disease.The signature was found to be 90% accurate. Patients with chronic pancreatitis were found to have lower levels of the same three proteins.Co-author Prof Nick Lemoine of the Barts Cancer Institute, said: "It's really exciting because for the first time we might be able to bring forward the window of opportunity for patients with pancreatic cancer - from something that is advanced and late stage to something that is early stage and potentially curable by surgery.
"Patients are usually diagnosed when the cancer is already at a terminal stage, but if diagnosed at stage 2, the survival rate is 20%, and at stage 1, the survival rate for patients with very small tumours can increase up to 60%." The Pancreatic Cancer Research Fund said this was "an exciting finding" and that an early diagnostic test was "much needed". Fiona Osgun, of Cancer Research UK, said: "At the moment, we're a long way from knowing if this research could lead to a test that would help detect pancreatic cancer at an early stage, or who that test might benefit.
"But research like this is vital as there's been little progress in improving survival for pancreatic cancer, and innovative approaches are needed."
Comments
Post a Comment